Genmab — Juli 2016
-
Dette Janssen støttede studie er igår publiceret i New England Medical Journal -
Interference of New Drugs with Compatibility Testing for Blood Transfusion
-
Opdateret plan for efterårets events/konferencer. http://ir.genmab.com/events.cfm#tab1
-
GENMAB AS REPLACES DELHAIZE GROUP IN THE S&P EUROPE 350 INDEX
-
Forrygende nyhed.
-
Kan se NBI er oppe med 15%(3390). Kan nogen forklare dette? Er på ferie i Sydfrankrig og har ikke fulgt så meget med.
-
ok tak Solsen
-
Det ville ellers være noget af en optur:-))
-
mon ikke NBI snart er over 3000 igen.
-
-
er der nogen med access? Det handler om mulig opjustering pba daras salgstal
-
måske den kommer i den trykte avis i morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind